The federal Food and Drug Administration nannies have been tormenting Americans for decades, which is no surprise given the pitfalls of putting bureaucrats in charge of such an important function as ...

Add Yahoo as a preferred source to see more of our stories on Google. The late, great Dennis Hopper was known for his scene-stealing work in front of the lens, but he also made a name for himself as ...

Create a Table in Notepad using the Formatting toolbar Insert a Table in Notepad using the right-click menu Create a Table in Notepad using Markdown Syntax. Press the left mouse button, and the table ...

President Donald Trump’s claims about prescription drug prices make no mathematical sense. But his team – including Health Secretary Robert F. Kennedy Jr. this week – keeps straining to defend them.

Around 100 members of San Francisco's addiction recovery community rallied on the steps of City Hall on Thursday to advocate for legislation proposing that new permanent supportive housing facilities ...

An executive order aims to speed up how quickly psychedelic drugs for mental illness can move through the regulatory process Podcaster Joe Rogan (middle right) hugs W. Bryan Hubbard, CEO of the ...

WASHINGTON, April 18 (Reuters) - U.S. President Donald Trump signed an executive order on Saturday intended to speed up access to medical research and treatment based on psychedelic ‌drugs. The order ...

RICHMOND, Va. — Gov. Abigail Spanberger has amended a bill passed by the General Assembly that would have created a Prescription Drug Affordability Board and could have lowered prices on 25 drugs. The ...

Today’s illicit chemists can quickly cook up drugs far more dangerous than fentanyl. By Jonathan Corum and Matt Richtel Illicit labs are creating new synthetic drugs at breakneck speed. Dangerous, ...

Scientists have created a programmable drug system that can zero in on cancer cells with unprecedented accuracy. Built from synthetic DNA, it only activates when it detects a precise combination of ...

Create Wellness, the company behind creatine gummies, has raised $20 million in growth capital. The company said it plans to use the Series B funding to accelerate its next phase of growth, including ...